SOD1 overexpression, RELA blockade, and diminished MyD88-mediated inflammation can enhance functional and metabolic recovery and greatly decreased myocardial infarction [21–23], while ADIPOR2 is required for revascularization [24]. The gene discussed is RELA; the disease is myocardial infarction.